Christopher Yanucil

1.4k total citations
15 papers, 627 citations indexed

About

Christopher Yanucil is a scholar working on Nephrology, Molecular Biology and Genetics. According to data from OpenAlex, Christopher Yanucil has authored 15 papers receiving a total of 627 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Nephrology, 10 papers in Molecular Biology and 6 papers in Genetics. Recurrent topics in Christopher Yanucil's work include Parathyroid Disorders and Treatments (11 papers), Fibroblast Growth Factor Research (10 papers) and Connective tissue disorders research (4 papers). Christopher Yanucil is often cited by papers focused on Parathyroid Disorders and Treatments (11 papers), Fibroblast Growth Factor Research (10 papers) and Connective tissue disorders research (4 papers). Christopher Yanucil collaborates with scholars based in United States, Germany and Venezuela. Christopher Yanucil's co-authors include Christian Faul, Alexander Grabner, Brian Czaya, Saurav Singh, Karla Schramm, Myles Wolf, Marcus Brand, Giovana Seno Di Marco, Stefanie Krick and René Bartz and has published in prestigious journals such as Journal of Clinical Investigation, Blood and Scientific Reports.

In The Last Decade

Christopher Yanucil

13 papers receiving 625 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Christopher Yanucil United States 9 468 263 205 128 116 15 627
Brian Czaya United States 9 430 0.9× 221 0.8× 182 0.9× 109 0.9× 117 1.0× 18 588
Lelia J. Summers United States 7 681 1.5× 261 1.0× 409 2.0× 173 1.4× 188 1.6× 7 821
Erica L. Clinkenbeard United States 15 615 1.3× 294 1.1× 343 1.7× 127 1.0× 147 1.3× 33 865
Fabiana G. Graciolli Brazil 12 792 1.7× 111 0.4× 219 1.1× 225 1.8× 298 2.6× 19 896
Joseph Boulanger United States 8 461 1.0× 165 0.6× 227 1.1× 100 0.8× 186 1.6× 8 627
Yuka Kinoshita Japan 17 535 1.1× 234 0.9× 241 1.2× 117 0.9× 147 1.3× 44 851
Ilka Edenhofer Switzerland 12 401 0.9× 258 1.0× 226 1.1× 86 0.7× 20 0.2× 20 719
Majd A.I. Mirza Sweden 10 1.0k 2.2× 435 1.7× 409 2.0× 382 3.0× 305 2.6× 10 1.2k
Simona Borsari Italy 19 813 1.7× 224 0.9× 469 2.3× 119 0.9× 65 0.6× 56 1.3k
Satsuki Shirota Japan 7 348 0.7× 109 0.4× 147 0.7× 79 0.6× 44 0.4× 13 473

Countries citing papers authored by Christopher Yanucil

Since Specialization
Citations

This map shows the geographic impact of Christopher Yanucil's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Christopher Yanucil with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Christopher Yanucil more than expected).

Fields of papers citing papers by Christopher Yanucil

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Christopher Yanucil. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Christopher Yanucil. The network helps show where Christopher Yanucil may publish in the future.

Co-authorship network of co-authors of Christopher Yanucil

This figure shows the co-authorship network connecting the top 25 collaborators of Christopher Yanucil. A scholar is included among the top collaborators of Christopher Yanucil based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Christopher Yanucil. Christopher Yanucil is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

15 of 15 papers shown
1.
Fajol, Abul, Qing Li, Alexis Sloan, et al.. (2025). Nephrotic syndrome in mice elevates FGF23 levels and leads to cardiac hypertrophy in the absence of hyperphosphatemia. Nephrology Dialysis Transplantation.
2.
Richter, Beatrice, Brian Czaya, Christopher Yanucil, et al.. (2024). FGFR4 Is Required for Concentric Growth of Cardiac Myocytes during Physiologic Cardiac Hypertrophy. Journal of Cardiovascular Development and Disease. 11(10). 320–320. 1 indexed citations
3.
Yanucil, Christopher & Christian Faul. (2024). Klotho. Journal of the American Society of Nephrology. 35(9). 1270–1273.
4.
Yanucil, Christopher, Dominik Kentrup, Xueyi Li, et al.. (2022). FGF21-FGFR4 signaling in cardiac myocytes promotes concentric cardiac hypertrophy in mouse models of diabetes. Scientific Reports. 12(1). 7326–7326. 19 indexed citations
5.
Yanucil, Christopher, Dominik Kentrup, Brian Czaya, et al.. (2022). Soluble α-klotho and heparin modulate the pathologic cardiac actions of fibroblast growth factor 23 in chronic kidney disease. Kidney International. 102(2). 261–279. 32 indexed citations
6.
Yanucil, Christopher, Shintaro Ide, Tomokazu Souma, et al.. (2019). FGFR4 does not contribute to progression of chronic kidney disease. Scientific Reports. 9(1). 14023–14023. 9 indexed citations
7.
Czaya, Brian, et al.. (2019). Hyperphosphatemia Contributes to Inflammation and Iron Dysregulation in Models of Normal and Impaired Renal Function. Blood. 134(Supplement_1). 2238–2238. 6 indexed citations
8.
Krick, Stefanie, Alexander Grabner, Nathalie Baumlin, et al.. (2018). Fibroblast growth factor 23 and Klotho contribute to airway inflammation. European Respiratory Journal. 52(1). 1800236–1800236. 76 indexed citations
9.
Grabner, Alexander, et al.. (2018). STAT3-enhancing germline mutations contribute to tumor-extrinsic immune evasion. Journal of Clinical Investigation. 128(5). 1867–1872. 16 indexed citations
10.
Czaya, Brian, Wacharee Seeherunvong, Saurav Singh, et al.. (2018). Cardioprotective Effects of Paricalcitol Alone and in Combination With FGF23 Receptor Inhibition in Chronic Renal Failure: Experimental and Clinical Studies. American Journal of Hypertension. 32(1). 34–44. 21 indexed citations
11.
Czaya, Brian, Saurav Singh, Christopher Yanucil, et al.. (2017). Induction of an Inflammatory Response in Primary Hepatocyte Cultures from Mice. Journal of Visualized Experiments. 7 indexed citations
12.
Grabner, Alexander, Karla Schramm, Neerupma Silswal, et al.. (2017). FGF23/FGFR4-mediated left ventricular hypertrophy is reversible. Scientific Reports. 7(1). 1993–1993. 100 indexed citations
13.
Czaya, Brian, Saurav Singh, Christopher Yanucil, et al.. (2017). Induction of an Inflammatory Response in Primary Hepatocyte Cultures from Mice. Journal of Visualized Experiments. 2 indexed citations
14.
Singh, Saurav, Alexander Grabner, Christopher Yanucil, et al.. (2016). Fibroblast growth factor 23 directly targets hepatocytes to promote inflammation in chronic kidney disease. Kidney International. 90(5). 985–996. 278 indexed citations
15.
Leifheit‐Nestler, Maren, Alexander Grabner, Beatrice Richter, et al.. (2016). Vitamin D treatment attenuates cardiac FGF23/FGFR4 signaling and hypertrophy in uremic rats. Nephrology Dialysis Transplantation. 32(9). 1493–1503. 60 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026